Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* OKAMOTO MERRICK D	2. Issuer Name and Ticker or Trading Symbol Marathon Patent Group, Inc. [ MARA ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Executive Officer
(Last) (First) (Middle) C/O MARATHON PATENT GROUP, INC., 1180 N. TOWNE CENTER DRIVE, SUITE 100	3. Date of Earliest Transaction (MM/DD/YYYY) 2/6/2021
(Street) LAS VEGAS, NV 89144 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/31/2020		C		978570 ⁽⁵⁾	A	$2.19	1458458	D
Common Stock	1/19/2021		C		908904 ⁽⁵⁾	A	$9.31	2367362	D
Common Stock	1/28/2021		C		897848 ⁽⁵⁾	A	$10.44	3265210	D
Common Stock	2/5/2021		C		1259449 ⁽⁵⁾	A	$13.59	4524659	D
Common Stock	2/18/2021		S		700000	D	$48.65	3824659	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
RSUs	$0 ⁽¹⁾	12/31/2020		A			1000000	⁽²⁾⁽⁴⁾	⁽²⁾	Common	1000000	$2.19	1454941 ⁽³⁾	D
RSUs	$0 ⁽¹⁾	12/31/2020		D			1000000	⁽²⁾⁽⁴⁾	⁽²⁾	Common	1000000	$2.19	454941	D
RSUs	$0 ⁽¹⁾	1/19/2021		A			1000000	⁽²⁾⁽⁴⁾	⁽²⁾	Common	1000000	$9.31	1454941	D
RSUs	$0 ⁽¹⁾	1/19/2021		D			1000000	⁽²⁾⁽⁴⁾	⁽²⁾	Common	1000000	$9.31	454941	D
RSUs	$0 ⁽¹⁾	1/28/2021		A			1000000	⁽²⁾⁽⁴⁾	⁽²⁾	Common	1000000	$10.44	1454941	D
RSUs	$0 ⁽¹⁾	1/28/2021		D			1000000	⁽²⁾⁽⁴⁾	⁽²⁾	Common	1000000	$10.44	454941	D
RSUs	$0 ⁽¹⁾	2/5/2021		A			1452608	⁽²⁾⁽⁴⁾	⁽²⁾	Common	1452608	$13.55	1907549	D
RSUs	$0 ⁽¹⁾	2/5/2021		D			1452608	⁽²⁾⁽⁴⁾	⁽²⁾	Common	1452608	$13.55	454941	D

Explanation of Responses:
(1)	Vested restricted stock units ("RSUs") granted under the Marathon Patent Group, Inc. 2018 Equity Incentive Plan (the "Plan") convert into shares of the Issuer's Common Stock on a one-for-one basis upon settlement by the Issuer in accordance with the procedures of the Plan.
(2)	On the date in column 3, in connection with the Reporting Person's service as a director of the Corporation, the Reporting Person was granted an award as stated in those rows denoted as "A" in column 4, which immediately vested in those rows denoted as "D" in column 4.
(3)	Represents the total direct and indirect beneficial ownership of the security held by the Reporting Person immediately following the issuance reported by this Form 4.
(4)	Immediate vesting.
(5)	Amount in column (4) is net of shares sold for tax purposes.

Remarks:
The four RSU grants in Table II are in conjunction with the following events: Merrick Okamoto, CEO was awarded was awarded a special bonus of 1,000,000 RSUs with immediate vesting. He was also granted the following: award of 1,000,000 RSUs when the company's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $500,000,000; award of 1,000,000 RSUs priced when the company's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $750,000,000; partial award of 1,452,608 RSUs priced at lowest closing stock price in past 30 trading days when the company's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $1,000,000,000 (another 547,392 RSUs to be granted when the Company obtains shareholder approval to increase its 2018 Equity Incentive Plan).

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
OKAMOTO MERRICK D C/O MARATHON PATENT GROUP, INC. 1180 N. TOWNE CENTER DRIVE, SUITE 100 LAS VEGAS, NV 89144	X		Chief Executive Officer